Inventor · disambiguated record
Judith Günther
Also filed as: GUENTHER JUDITH · GÜNTHER JUDITH
21 granted patents·10 pending applications·179 citations·filing 2006–2023
94Inventor score
Top patents by PatentIndex Score
31 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0294US11130745B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2020·Granted Sep 28, 2021·4 cites·19 claims
- 0394US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0492US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0592US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0690US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0790US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0890US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0990US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 1089US10815215B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2017·Granted Oct 27, 2020·5 cites·20 claims
- 1188US7750000B2Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicamentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Jul 6, 2010·24 cites·2 claims
- 1287US11713304B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2021·Granted Aug 1, 2023·1 cites·11 claims
- 1385US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 1484US10968216B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2017·Granted Apr 6, 2021·3 cites·16 claims
- 1578US12486248B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 1678US11304946B22-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonistsBAYER AG·Filed 2018·Granted Apr 19, 2022·2 cites·11 claims
- 1775US10370339B2N-Methylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Aug 6, 2019·2 cites·15 claims
- 1874US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 1970US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 2069US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 2168US11524944B22-phenylpyrimidine-4-carboxamides as AHR inhibitorsBAYER AG·Filed 2018·Granted Dec 13, 2022·1 cites·11 claims
- 2267US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2359US11787797B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2021·Granted Oct 17, 2023·0 cites·2 claims
- 2457US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2554US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 2650US2020360531A1Antibody drug conjugates (adcs) with nampt inhibitorsBAYER AG·Filed 2019·Application pending·0 cites
- 2748US8003787B2Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 23, 2011·0 cites·21 claims
- 2848US2023113037A1[1,2,4]triazolo[1,5-c]quinazolin-5-aminesBAYER AG·Filed 2020·Application pending·0 cites
- 2948US2022411381A1Pyrimidinedione derivativesBAYER AG·Filed 2020·Application pending·0 cites
- 3044US2017037028A1Glucose transport inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3139US2014288069A1Amino-substituted imidazopyridazines as mknk1 kinase inhibitorsEIS KNUT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Judith Günther files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →